Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Frontiers in Oncology

Hubing Shi¹  Xuelei Ma¹  Xiaomeng Yin¹  Ruoning Yang²  Haiyang Wang³  Udo S. Gaipl⁴  Benjamin Frey⁴ 

[1] Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China;Department of Breast Surgery, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China;Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China;Translational Radiobiology, Universitätsklinikum Erlangen, Erlangen, Germany;

关键词: editorial;    lung cancer;    immunotherapy;    immune-related adverse events (IRAEs);    management;    pathogenesis;   

DOI  :  10.3389/fonc.2022.898576

来源: DOAJ

【 授权许可】

Unknown